The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, ...

COCP READ THE FULL COCP RESEARCH REPORT Business Update Update on CDI-988 On January 8, 2025, Cocrystal Pharma, Inc.

But while platform trials have the potential to be more effective and less expensive than traditional trials, challenges ...

Strengthened the cash balance to provide runway into 2027, allowing Allarity to accelerate stenoparib's clinical development, ...

Imunon has announced the alignment of the FDA with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol.

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

An invaluable resource is being starved to death with no scientific or ethical justification ...

Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with ...

Ainnova has hired an ophthalmologist, who is assisting in drafting the requirements for the clinical trial protocol that the Company's Contract Research Organization (CRO), Fortrea, has requested.

Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...